The issue was settled in the US court system even though the incidents occurred in Canada and Chile. STIM and MariCal are the owners and patent holders for the SuperSmolt technology. All parties have chosen to keep the details of the settlement confidential
“We are satisfied with reaching an agreement that ends a long-lasting dispute,” said Jim-Roger Nordly, CEO for STIM.
“We have spent great resources, over many years, on our R&D efforts to create biologically based technology aimed at improved production, lower mortality and higher growth performance in aquaculture.
“It goes without saying that our efforts don’t always pay off, and the patent institute is created to protect new ideas and concepts that might, and to be an incentive to continue the development of such. Together with MariCal we have succeeded in actually bringing the aquaculture industry a significant step forward.”
SuperSmolt and SuperSmolt Feed Only launched in 2014. It is used in all major salmon producing countries. The technology contributes to the production of earlier and bigger smolts, reduces mortality, betters fish welfare and leads to significantly higher growth performance after sea transfer. STIM (previously Europharma) bought the rights to the technology in 2008 and preceded to develop SuperSmolt Feed Only.
MariCal is a bio-technology company operating in animal health and nutrition and were behind the development of the original SuperSmolt® concept.